Nearly all immune responses are the result of TCR signaling in the context of costimulation. Thus, the processes by which TCR and costimulatory signals are sensed and summed define distinct outcomes of TCR engagement, including activation, anergy or death. An understanding of signal integration at the cellular level is essential if we are to understand the pathological consequences of these cellular outcomes, which include immunodeficiency and autoimmunity. While many of the proximal and distal events in T cell activation are well studied, the molecular mechanisms underlying control of calcium entry, an essential feature of activation, are not fully understood. We will contribute to the goals of the Program by focusing specifically on TFII-I, which is abundantly expressed in lymphoid cells and serves a prominent cytosolic ? function as a negative regulator of receptor-mediated calcium entry. Supression of calcium entry requires two sites within TFII-I that mediate binding to PLC-gamma: a tyrosine residue that supports phosphorylationdependent binding and a neighboring interval that interacts with the PLC-gamma split PH domain. We found that TFII-I exerts its action by decreasing the density of cell-surface TRPC3 receptors. We propose that TFII-I antagonizes calcium entry by interfering with the ability of PLC-gamma to promote transport of TRPC3 channels to the plasma membrane. In a>human T cell line, removal of TFII-I results in a substantial increase in calcium influx upon T cell receptor engagement and upregulates expression of the inhibitory protein Spryl. To elucidate a role for TFII-I in regulating calcium entry in lymphocytes, we propose three aims: (1) to assess the mechanism by which TFII-I modulates calcium entry in response to TCR engagement;(2) to examine the effects of TFII-I ablation on antigen-specific T cell responses;and (3) to identify specific tyrosine phosphorylation pathways that regulate TFII-I activity. Modulation of calcium entry is likely to play a critical role in defining distinct outcomes of TCR engagement;consequently the proposed studies are highly synergistic with all other components of the Program. Because anergizing signals are capable of uncoupling TCR engagement from calcium entry, determining how calcium entry is modulated by TFII-I may prove useful in understanding how activated and anergic states are distinguished.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI072677-02
Application #
7914315
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
2
Fiscal Year
2009
Total Cost
$319,558
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Schappert, Anna; Schneck, Jonathan P; Suarez, Lauren et al. (2018) Soluble MHC class I complexes for targeted immunotherapy. Life Sci 209:255-258
Hickey, John W; Isser, Ariel Y; Vicente, Fernando P et al. (2018) Efficient magnetic enrichment of antigen-specific T cells by engineering particle properties. Biomaterials 187:105-116
Bettencourt, Ian A; Powell, Jonathan D (2017) Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation. J Immunol 198:999-1005
Kosmides, A K; Meyer, R A; Hickey, J W et al. (2017) Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma. Biomaterials 118:16-26
Tiper, Irina V; Temkin, Sarah M; Spiegel, Sarah et al. (2016) VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells. Clin Cancer Res 22:4249-58
Pollizzi, Kristen N; Sun, Im-Hong; Patel, Chirag H et al. (2016) Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8(+) T cell differentiation. Nat Immunol 17:704-11
Schütz, Christian; Varela, Juan Carlos; Perica, Karlo et al. (2016) Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells. Oncotarget 7:68503-68512
Pollizzi, Kristen N; Waickman, Adam T; Patel, Chirag H et al. (2015) Cellular size as a means of tracking mTOR activity and cell fate of CD4+ T cells upon antigen recognition. PLoS One 10:e0121710
Shaikh, Saame Raza; Boyle, Sarah; Edidin, Michael (2015) A high fat diet containing saturated but not unsaturated fatty acids enhances T cell receptor clustering on the nanoscale. Prostaglandins Leukot Essent Fatty Acids 100:1-4
Makowski, Stefanie L; Wang, Zhaoquan; Pomerantz, Joel L (2015) A protease-independent function for SPPL3 in NFAT activation. Mol Cell Biol 35:451-67

Showing the most recent 10 out of 37 publications